InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Thomas Bonnefont, COO & CCO. Officer active across 1 companies, notably Median Technologies. Cumulatively, 2 reports have been recorded. Total volume traded: €67k. The latest transaction was filed on 21 October 2023 (Acquisition). Regulator: AMF. All data is openly available.
Declarations2 total
€66,75015,000 shares@ €4.450.096% mcap100.0% of flow
ActionEuronext Paris
2023DD942067·
Ideal exit: 17 Jul 2024 (T+270)
015,000 shares0
actions gratuitesHors plateforme de négociation
2022DD872047·
Ideal exit: 18 Jul 2023 (T+270)
2 of 2 declarations
About Thomas Bonnefont
Thomas Bonnefont is the COO and CCO of Eyonis and iBiopsy. In these roles, he is responsible for the operations and business development of the companies. Thomas works on optimizing operational processes and implementing growth strategies. His expertise in the sector is essential for the success of Eyonis and iBiopsy's initiatives.
